EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Asia Pacific

Chinese researchers use traditional ink for cancer treatment

A traditional Chinese ink called Hu-Kaiwen ink (Hu-ink) has similar properties to the nanomaterials used in Photo thermal therapy.   A group of Chinese resea...
Continue Reading →
Asia Pacific

Korean scientists use bilirubin nanoparticles for cancer therapy

The team expects a more accurate diagnosis of tumors through this technology.   A team of scientists at Korea Advanced Institute of Science and Technology ha...
Continue Reading →
Asia Pacific

Serum Institute touts phase 3 rotavirus data as it preps first deliveries

Affordable vaccine maker Serum Institute of India has new results to trumpet from a phase 3 trial of its heat-stable rotavirus vaccine as it preps to deliver milli...
Continue Reading →
Asia Pacific

Piramal Pharma Solutions Names John Fowler as its Chief Operating Officer

 Piramal Pharma Solutions (PPS), part of Piramal Enterprises Limited, announce the appointment of John Fowler as its Chief Operating Officer. PPS is a leader in Integ...
Continue Reading →
Asia Pacific

WuXi AppTec Immunotherapy Report: Biotech Sector Will Drive Biggest Advancements in Decades on Cancer Treatments

Small nimble biotechs to introduce a ‘golden age’ of next generation therapies like CAR-T, combination therapies, innate immune system approaches, and newer check-poi...
Continue Reading →
Asia Pacific

China FDA, US FDA and industry leaders debate MAH pilot being adopted nationwide

STA Pharmaceutical Co., Ltd. (STA)  – a WuXi AppTec subsidiary and a leading open-access capability and technology platform for small molecule pharmaceutical developm...
Continue Reading →
Asia Pacific

International Pharma Regulatory Summit 27th-28th July 2017, Singapore

Effectively interpret complicated regulatory guidelines to fast track your drug approval process Early Confirmed Speakers: Dr Stephen Hsu, Associate Director ...
Continue Reading →
Asia Pacific

Global Japanese Pharmaceutical Firm Selects iCardiac for Oncology Clinical Trial

iCardiac will use its proprietary Rapid QT service to optimize and accelerate subject enrollment iCardiac Technologies, Inc., a leading innovator and provider of cent...
Continue Reading →
Asia Pacific

Live from CPhI Japan 2017: Japanese pharma companies predict a 17% growth in 2017

CPhI research shows that the biologics and generics sector are driving growth over the next year Tokyo, 21st April 2017: CPhI Japan – organised by UBM EMEA and UBM As...
Continue Reading →
BeiGene bags approval to start Chinese trials of Lynparza competitor
Asia Pacific

BeiGene bags approval to start Chinese trials of Lynparza competitor

BeiGene is all set to start Chinese trials of its PARP inhibitor BGB-290, one of a portfolio of homegrown drugs that aims to challenge Western dominance in cancer R&a...
Continue Reading →
Catalyst: 12th January 2026
Quotient